Organization
Trinity St. James Cancer Institute
3 abstracts
Abstract
Prospective evaluation of the breast microbiome and tumor microenvironment-related biomarkers of response to neoadjuvant systemic therapy in triple negative breast cancer.Org: Cancer Research @UCC, CUH/UCC Cancer Centre, HRB Clinical Research Facility, School of Pharmacy and Pharmaceutical Sciences, Trinity Biomedical Sciences Institute,
Abstract
KEYNOTE-859 study of pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Outcomes in the protocol-specified PD-L1–selected populations.Org: Yonsei Cancer Center, Yonsei University Health System, Maria Sklodowska-Curie National Research Institute of Oncology, James Lind Cancer Research Center, Temuco, Chile, Harbin Medical University Cancer Hospital, Asan Medical Center,
Abstract
Modifiable risk factors and risk of colorectal and endometrial cancer in Lynch syndrome: A systematic review and meta-analysis.Org: Mater Misericordiae University Hospital, Trinity College Dublin, Cancer Trials Ireland, Trinity St. James Cancer Institute, St James's Hospital & Trinity College Dublin,